HemaCord (New York Blood Center)
Welcome to the PulseAid listing for the HemaCord drug offered from New York Blood Center. This Allogeneic Cord Blood Hematopoietic Progenitor Cell Therapy [EPC],Hematopoietic Stem Cells [Chemical/Ingredient],Cells, Allogeneic [Chemical/Ingredient] pharmaceutical is classified as a CELLULAR THERAPY. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same CELLULAR THERAPY drug type category.
| LABELER NAME / MANUFACTURER: | New York Blood Center |
| NON-PROPRIETARY NAME: | HUMAN CORD BLOOD HEMATOPOIETIC PROGENITOR CELL |
| SUBSTANCE NAME: | HUMAN CORD BLOOD HEMATOPOIETIC PROGENITOR CELL |
| TYPE: | CELLULAR THERAPY |
| PHARMA CLASS: | Allogeneic Cord Blood Hematopoietic Progenitor Cell Therapy [EPC],Hematopoietic Stem Cells [Chemical/Ingredient],Cells, Allogeneic [Chemical/Ingredient] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION |
| MARKETING CATEGORY NAME: | BLA |
| START MARKETING DATE: | 2011-11-10 |
| END MARKETING DATE: | 0000-00-00 |
HemaCord CELLULAR THERAPY Details:
| Item Description | HemaCord from New York Blood Center |
| LABELER NAME: | New York Blood Center |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 500000000(1/25mL) |
| START MARKETING DATE: | 2011-11-10 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 76489-001_3423e193-0e4c-4c64-9e56-cd6ff57ac316 |
| PRODUCT NDC: | 76489-001 |
| APPLICATION NUMBER: | BLA125397 |
Other HUMAN CORD BLOOD HEMATOPOIETIC PROGENITOR CELL Pharmaceutical Manufacturers / Labelers:
